Stina Syvänen
Orcid: 0000-0002-8196-4041
According to our database1,
Stina Syvänen
authored at least 11 papers
between 2006 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2023
NeuroImage, August, 2023
2021
<i>In vivo</i> imaging of synaptic density with [<sup>11</sup>C]UCB-J PET in two mouse models of neurodegenerative disease.
NeuroImage, 2021
2019
High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain.
NeuroImage, 2019
2017
A bispecific Tribody PET radioligand for visualization of amyloid-beta protofibrils - a new concept for neuroimaging.
NeuroImage, 2017
Combined PET and microdialysis for in vivo estimation of drug blood-brain barrier transport and brain unbound concentrations.
NeuroImage, 2017
2011
Simultaneous in vivo measurements of receptor density and affinity using [<sup>11</sup>C]flumazenil and positron emission tomography: Comparison of full saturation and steady state methods.
NeuroImage, 2011
(R)-[<sup>11</sup>C]Verapamil PET studies to assess changes in P-glycoprotein expression and functionality in rat blood-brain barrier after exposure to kainate-induced status epilepticus.
BMC Medical Imaging, 2011
2010
Initial PET studies in rats with novel radiotracer [11C]D617 and comparison with (R)-[11C]verapamil.
NeuroImage, 2010
Comparison of two methods for estimating B<sub>max</sub> and K<sub>D</sub> of [<sup>11</sup>C]flumazenil in rat brain.
NeuroImage, 2010
2007
Synthesis of two potential NK<sub>1</sub>-receptor ligands using [1-<sup>11</sup>C]ethyl iodide and [1-<sup>11</sup>C]propyl iodide and initial PET-imaging.
BMC Medical Imaging, 2007
2006
Duration and degree of cyclosporin induced P-glycoprotein inhibition in the rat blood-brain barrier can be studied with PET.
NeuroImage, 2006